AB2 Bio Completes Enrolment in Pivotal Phase 3 Trial of
Topline pivotal Phase 3 results expected during second half of 2023Potential new treatment option in ultra-rare,
Globe Newswire7-03-2023, 15:05
ZetrOZ Systems to Attend and Present at the Big Sky 31-01-2023, 03:54